Serosep are leading suppliers of cutting edge molecular diagnostic tests for reliable results across many applications.
As one of the leading manufacturers of medical laboratory diagnostics worldwide, EUROIMMUN stands for innovation. More than 3,500 employees in 17 countries develop, produce and sell test systems to support the diagnosis of diseases, as well as software and automation solutions for the performance and evaluation of these tests.
Euroimmun provide an extensive array of test systems, laboratory instruments and software solutions. Laboratories in over 140 countries use EUROIMMUN products for the diagnosis of autoimmune, infection, allergy, and molecular genetic diagnostics. The company’s portfolio encompasses indirect immunofluorescence assays, ELISAs, immunoblots, radioimmunoassays, chemiluminescence immunoassays (ChLIA), molecular genetic test systems, and automation technologies. Instrumentation from Euroimmun provides you with flexible solutions to streamline the workflow in your laboratory while the software solutions ensure automated evaluation for fast, reliable and objective results of molecular analyses.
PathoNostics was founded in 2011 in Maastricht, The Netherlands and became an important player in the fungal diagnostic field. PathoNostics offers a range of diagnostic real-time PCR kits for the detection of fungal infections. The company currently have five products on the market: AsperGenius®, DermaGenius®, PneumoGenius®, MucorGenius® and CandidaGenius®.
At PathoNostics, the objective is to rapidly detect the disease-causing fungus and simultaneously identify antifungal resistance, allowing clinicians to initiate a dedicated and timely therapy and save on costs and lives. By using these real-time PCR kits, incorrect or unnecessary medical treatment, side effects, and costs can be avoided. The early diagnosis of fungal infections can greatly improve the clinical success and infection control.
Alifax is an Italian company specializing in the development, production and distribution of clinical diagnostic instrumentation for laboratory automation. Alifax pride themselves on understanding the markets needs and promptly answering worldwide demands through its technical scientific infrastructure represented by highly qualified staff in the field of laboratory medicine, engineering and information technology. Alifax is strongly oriented towards scientific research and technological innovation supported by a constant program of investment.
As one of the leading manufacturers of medical laboratory diagnostics worldwide, EUROIMMUN stands for innovation. More than 3,500 employees in 17 countries develop, produce and sell test systems to support the diagnosis of diseases, as well as software and automation solutions for the performance and evaluation of these tests.
Euroimmun provide an extensive array of test systems, laboratory instruments and software solutions. Laboratories in over 140 countries use EUROIMMUN products for the diagnosis of autoimmune, infection, allergy, and molecular genetic diagnostics. The company’s portfolio encompasses indirect immunofluorescence assays, ELISAs, immunoblots, radioimmunoassays, chemiluminescence immunoassays (ChLIA), molecular genetic test systems, and automation technologies. Instrumentation from Euroimmun provides you with flexible solutions to streamline the workflow in your laboratory while the software solutions ensure automated evaluation for fast, reliable and objective results of molecular analyses.
PathoNostics was founded in 2011 in Maastricht, The Netherlands and became an important player in the fungal diagnostic field. PathoNostics offers a range of diagnostic real-time PCR kits for the detection of fungal infections. The company currently have five products on the market: AsperGenius®, DermaGenius®, PneumoGenius®, MucorGenius® and CandidaGenius®.
At PathoNostics, the objective is to rapidly detect the disease-causing fungus and simultaneously identify antifungal resistance, allowing clinicians to initiate a dedicated and timely therapy and save on costs and lives. By using these real-time PCR kits, incorrect or unnecessary medical treatment, side effects, and costs can be avoided. The early diagnosis of fungal infections can greatly improve the clinical success and infection control.
